MedPath
TGA Approval

METAGENICS KIDNEY CARE (394051)

394051

METAGENICS KIDNEY CARE

Metagenics (Aust) Pty Ltd

August 18, 2022

Medicine

Medicine

Active

Listed

Active Ingredients

d-alpha-tocopheryl acid succinate

Equisetum arvense

Galium aparine

pyridoxine hydrochloride

quercetin

thiamine hydrochloride

Zea mays

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

METAGENICS KIDNEY CARE (394051) - TGA 批准文号 | MedPath